Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Mid-range Performer

5098.5000 -196.00 (-3.70%)

NSE May 30, 2025 15:31 PM

Volume: 724.8K

High volume today

Alkem Laboratories Ltd.

10 Aug 2023

5098.50

-3.70%

Alkem Labs (SELL): International sales fuel growth; margin recovery positive

Sell: Alkem Laboratories Ltd.

Target

BOB Capital Markets Ltd.

Q1 revenue/EBITDA a beat as international business outperformed; adj. PAT growth in line with consensus at 65% QoQ

Number of FII/FPI investors increased from 524 to 535 in Mar 2025 qtr.